Clinical Trial Update: A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants [Phase 3]

View source ↗

Summary

A long-term extension study of guselkumab in pediatric participants with Crohn's disease, ulcerative colitis, psoriatic arthritis, and juvenile arthritis is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Juvenile Idiopathic Arthritis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohns Disease, Colitis, Ulcerative | Phase 3 | Status: RECRUITING